General MM

Shaji Kumar | ESH MM 2018 | New end-points and new design for clinical trials

L: English

4th International Conference on Multiple Myeloma, European School of Haematology, 5–7 October, Mandelieu, France
Listen to Shaji Kumar discuss how the emergence of new treatment agents calls for new ways in designing clinical trials and re-defining relevant end-points.
Download this article:

You can now download this article in Adobe PDF® format.

Download as PDF